{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T23:10:55Z","timestamp":1790637055216,"version":"4.1.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,26]],"date-time":"2022-11-26T00:00:00Z","timestamp":1669420800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,26]],"date-time":"2022-11-26T00:00:00Z","timestamp":1669420800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81672181"],"award-info":[{"award-number":["81672181"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82072397"],"award-info":[{"award-number":["82072397"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Youth Doctor Collaborative Innovation Team","award":["QC201903"],"award-info":[{"award-number":["QC201903"]}]},{"name":"Project of Biobank","award":["YBKA201911"],"award-info":[{"award-number":["YBKA201911"]}]},{"name":"Shanghai Municipal Education Commission Two-hundred Talent"},{"name":"Youth Talent Program from Shanghai Health System","award":["2022YQ020"],"award-info":[{"award-number":["2022YQ020"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The COVID-19 pandemic has become a huge threat to human health, infecting millions of people worldwide and causing enormous economic losses. Many novel small molecule drugs have been developed to treat patients with COVID-19, including Paxlovid, which block the synthesis of virus-related proteins and replication of viral RNA, respectively.\u00a0Despite satisfactory clinical trial results, attention is now being paid to the long-term side effects of these antiviral drugs on the musculoskeletal system. To date, no study has reported the possible side effects, such as osteoarthritis, of Paxlovid. This study explored the effects of antiviral drug, Paxlovid, on chondrocyte proliferation and differentiation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In this study, both in vitro and in vivo studies were performed to determine the effect of Paxlovid on chondrocyte degeneration and senescence. Furthermore, we explored the possible mechanism behind Paxlovid-induced acceleration of cartilage degeneration using transcriptome sequencing and related inhibitors were adopted to verify the downstream pathways behind such phenomenon.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Paxlovid significantly inhibited chondrocyte extracellular matrix protein secretion. Additionally, Paxlovid significantly induced endoplasmic reticulum stress, oxidative stress, and downstream ferroptosis, thus accelerating the senescence and degeneration of chondrocytes. In vivo experiments showed that intraperitoneal injection of Paxlovid for 1\u00a0week exacerbated cartilage abrasion and accelerated the development of osteoarthritis in a mouse model.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Paxlovid accelerated cartilage degeneration and osteoarthritis development, potentially by inducing endoplasmic reticulum stress and oxidative stress. Long-term follow-up is needed with special attention to the occurrence and development of osteoarthritis in patients treated with Paxlovid.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12967-022-03770-4","type":"journal-article","created":{"date-parts":[[2022,11,27]],"date-time":"2022-11-27T01:18:52Z","timestamp":1669511932000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Paxlovid accelerates cartilage degeneration and senescence through activating endoplasmic reticulum stress and interfering redox homeostasis"],"prefix":"10.1186","volume":"20","author":[{"given":"Keyu","family":"Kong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongyun","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuzhuo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kewei","family":"Rong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghao","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingwei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiwu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zanjing","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,26]]},"reference":[{"key":"3770_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-04856-1","author":"R Uraki","year":"2022","unstructured":"Uraki R, Kiso M, Iida S, Imai M, Takashita E, Kuroda M, et al. Characterization and antiviral susceptibility of SARS-CoV-2 Omicron\/BA.2. Nature. 2022. https:\/\/doi.org\/10.1038\/s41586-022-04856-1.","journal-title":"Nature"},{"issue":"4","key":"3770_CR2","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1002\/mco2.110","volume":"2","author":"X He","year":"2020","unstructured":"He X, Hong W, Pan X, Lu G, Wei X. SARS-CoV-2 Omicron variant: characteristics and prevention. MedComm. 2020;2(4):838\u201345.","journal-title":"MedComm"},{"issue":"24","key":"3770_CR3","first-page":"8019","volume":"25","author":"S Kannan","year":"2021","unstructured":"Kannan S, Shaik Syed Ali P, Sheeza A. Omicron (B.1.1.529)\u2013variant of concern\u2013molecular profile and epidemiology: a mini review. Eur Rev Med Pharmacol Sci. 2021;25(24):8019\u201322.","journal-title":"Eur Rev Med Pharmacol Sci."},{"issue":"10332","key":"3770_CR4","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1016\/S0140-6736(22)00462-7","volume":"399","author":"T Nyberg","year":"2022","unstructured":"Nyberg T, Ferguson NM, Nash SG, Webster HH, Flaxman S, Andrews N, et al. Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617 2) variants in England: a cohort study. Lancet. 2022;399(10332):1303\u201312.","journal-title":"Lancet"},{"key":"3770_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2021.698111","volume":"9","author":"A Joshi","year":"2021","unstructured":"Joshi A, Kaur M, Kaur R, Grover A, Nash D, El-Mohandes A. Predictors of COVID-19 vaccine acceptance, intention, and hesitancy: a scoping review. Front Public Health. 2021;9: 698111.","journal-title":"Front Public Health"},{"issue":"5","key":"3770_CR6","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1056\/NEJMoa2021801","volume":"384","author":"O Mitj\u00e0","year":"2021","unstructured":"Mitj\u00e0 O, Corbacho-Monn\u00e9 M, Ubals M, Alemany A, Su\u00f1er C, Teb\u00e9 C, et al. A cluster-randomized trial of hydroxychloroquine for prevention of covid-19. N Engl J Med. 2021;384(5):417\u201327.","journal-title":"N Engl J Med"},{"issue":"19","key":"3770_CR7","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1056\/NEJMoa2001282","volume":"382","author":"B Cao","year":"2020","unstructured":"Cao B, Wang Y, Wen D, Liu W, Wang J, Fan G, et al. A trial of Lopinavir-Ritonavir in adults hospitalized with severe covid-19. N Engl J Med. 2020;382(19):1787\u201399.","journal-title":"N Engl J Med"},{"key":"3770_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2021.173926","volume":"897","author":"A Rezagholizadeh","year":"2021","unstructured":"Rezagholizadeh A, Khiali S, Sarbakhsh P, Entezari-Maleki T. Remdesivir for treatment of COVID-19; an updated systematic review and meta-analysis. Eur J Pharmacol. 2021;897: 173926.","journal-title":"Eur J Pharmacol"},{"key":"3770_CR9","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciac180","author":"LD Saravolatz","year":"2022","unstructured":"Saravolatz LD, Depcinski S, Sharma M. Molnupiravir and Nirmatrelvir-ritonavir: oral COVID antiviral drugs. Clin Infect Dis. 2022. https:\/\/doi.org\/10.1093\/cid\/ciac180.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"3770_CR10","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1056\/NEJMoa2116044","volume":"386","author":"A Jayk Bernal","year":"2022","unstructured":"Jayk Bernal A, Gomes da Silva MM, Musungaie DB, Kovalchuk E, Gonzalez A, Delos Reyes V, et al. Molnupiravir for oral treatment of covid-19 in nonhospitalized patients. N Engl J Med. 2022;386(6):509\u201320.","journal-title":"N Engl J Med"},{"key":"3770_CR11","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n2713","volume":"375","author":"E Mahase","year":"2021","unstructured":"Mahase E. Covid-19: Pfizer\u2019s paxlovid is 89% effective in patients at risk of serious illness, company reports. BMJ. 2021;375: n2713.","journal-title":"BMJ"},{"issue":"5","key":"3770_CR12","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1002\/jmv.27540","volume":"94","author":"Z Wang","year":"2022","unstructured":"Wang Z, Yang L. In the age of omicron variant: paxlovid raises new hopes of COVID-19 recovery. J Med Virol. 2022;94(5):1766\u20137.","journal-title":"J Med Virol"},{"key":"3770_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2021.100794","volume":"59","author":"S Dro\u017cd\u017cal","year":"2021","unstructured":"Dro\u017cd\u017cal S, Rosik J, Lechowicz K, Machaj F, Szostak B, Przybyci\u0144ski J, et al. An update on drugs with therapeutic potential for SARS-CoV-2 (COVID-19) treatment. Drug Resist Updat. 2021;59: 100794.","journal-title":"Drug Resist Updat"},{"key":"3770_CR14","unstructured":"FDA. Fact Sheet For Healthcare Providers: Emergency Use Authorization For Paxlovid. FDA. 2022. www.fda.gov. Accessed 30 Dec 2021."},{"key":"3770_CR15","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.2646","author":"C Marzolini","year":"2022","unstructured":"Marzolini C, Kuritzkes DR, Marra F, Boyle A, Gibbons S, Flexner C, et al. Recommendations for the management of drug-drug interactions between the COVID-19 antiviral nirmatrelvir\/ritonavir (Paxlovid(\u00ae) ) and comedications. Clin Pharmacol Ther. 2022. https:\/\/doi.org\/10.1002\/cpt.2646.","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"3770_CR16","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1053\/j.ajkd.2022.01.001","volume":"79","author":"S Fishbane","year":"2022","unstructured":"Fishbane S, Hirsch JS, Nair V. Special considerations for paxlovid treatment among transplant recipients With SARS-CoV-2 infection. Am J Kidney Dis. 2022;79(4):480\u20132.","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"3770_CR17","doi-asserted-by":"publisher","DOI":"10.1002\/adbi.202200007","volume":"6","author":"J Gao","year":"2022","unstructured":"Gao J, Mei H, Sun J, Li H, Huang Y, Tang Y, et al. Neuropilin-1-mediated SARS-CoV-2 infection in bone marrow-derived macrophages inhibits osteoclast differentiation. Adv Biol (Weinh). 2022;6(5): e2200007.","journal-title":"Adv Biol (Weinh)"},{"issue":"1","key":"3770_CR18","doi-asserted-by":"publisher","first-page":"2539","DOI":"10.1038\/s41467-022-30195-w","volume":"13","author":"W Qiao","year":"2022","unstructured":"Qiao W, Lau HE, Xie H, Poon VK, Chan CC, Chu H, et al. SARS-CoV-2 infection induces inflammatory bone loss in golden Syrian hamsters. Nat Commun. 2022;13(1):2539.","journal-title":"Nat Commun"},{"issue":"2","key":"3770_CR19","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1097\/BOR.0000000000000479","volume":"30","author":"ER Vina","year":"2018","unstructured":"Vina ER, Kwoh CK. Epidemiology of osteoarthritis: literature update. Curr Opin Rheumatol. 2018;30(2):160\u20137.","journal-title":"Curr Opin Rheumatol"},{"key":"3770_CR20","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.jot.2021.05.006","volume":"29","author":"R Xia","year":"2021","unstructured":"Xia R, Zhai Z, Zhang J, Yu D, Wang L, Mao Y, et al. Verification and clinical translation of a newly designed \u201cSkywalker\u201d robot for total knee arthroplasty: a prospective clinical study. J Orthop Translat. 2021;29:143\u201351.","journal-title":"J Orthop Translat"},{"issue":"9991","key":"3770_CR21","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/S0140-6736(14)60802-3","volume":"386","author":"S Glyn-Jones","year":"2015","unstructured":"Glyn-Jones S, Palmer AJ, Agricola R, Price AJ, Vincent TL, Weinans H, et al. Osteoarthritis. Lancet. 2015;386(9991):376\u201387.","journal-title":"Lancet"},{"issue":"1","key":"3770_CR22","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1038\/s41467-021-21948-0","volume":"12","author":"G Zhen","year":"2021","unstructured":"Zhen G, Guo Q, Li Y, Wu C, Zhu S, Wang R, et al. Mechanical stress determines the configuration of TGF\u03b2 activation in articular cartilage. Nat Commun. 2021;12(1):1706.","journal-title":"Nat Commun"},{"issue":"10","key":"3770_CR23","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1038\/nrd.2017.116","volume":"16","author":"BG Childs","year":"2017","unstructured":"Childs BG, Gluscevic M, Baker DJ, Laberge RM, Marquess D, Dananberg J, et al. Senescent cells: an emerging target for diseases of ageing. Nat Rev Drug Discov. 2017;16(10):718\u201335.","journal-title":"Nat Rev Drug Discov"},{"key":"3770_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2020.109880","volume":"78","author":"Y Rellmann","year":"2021","unstructured":"Rellmann Y, Eidhof E, Dreier R. Review: ER stress-induced cell death in osteoarthritic cartilage. Cell Signal. 2021;78: 109880.","journal-title":"Cell Signal"},{"key":"3770_CR25","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.22275.1","author":"MD Briggs","year":"2020","unstructured":"Briggs MD, Dennis EP, Dietmar HF, Pirog KA. New developments in chondrocyte ER stress and\u00a0related diseases. F1000Res. 2020. https:\/\/doi.org\/10.12688\/f1000research.22275.1.","journal-title":"F1000Res"},{"issue":"2","key":"3770_CR26","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/s41419-020-2298-2","volume":"11","author":"J Li","year":"2020","unstructured":"Li J, Cao F, Yin HL, Huang ZJ, Lin ZT, Mao N, et al. Ferroptosis: past, present and future. Cell Death Dis. 2020;11(2):88.","journal-title":"Cell Death Dis"},{"key":"3770_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.789948","volume":"9","author":"J Yang","year":"2021","unstructured":"Yang J, Hu S, Bian Y, Yao J, Wang D, Liu X, et al. Targeting cell death: pyroptosis, ferroptosis, apoptosis and necroptosis in osteoarthritis. Front Cell Dev Biol. 2021;9: 789948.","journal-title":"Front Cell Dev Biol"},{"key":"3770_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2022.103847","volume":"76","author":"Y Miao","year":"2022","unstructured":"Miao Y, Chen Y, Xue F, Liu K, Zhu B, Gao J, et al. Contribution of ferroptosis and GPX4\u2019s dual functions to osteoarthritis progression. EBioMedicine. 2022;76: 103847.","journal-title":"EBioMedicine"},{"key":"3770_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.791376","volume":"13","author":"Z Guo","year":"2022","unstructured":"Guo Z, Lin J, Sun K, Guo J, Yao X, Wang G, et al. Deferoxamine alleviates osteoarthritis by inhibiting chondrocyte ferroptosis and activating the Nrf2 pathway. Front Pharmacol. 2022;13: 791376.","journal-title":"Front Pharmacol"},{"issue":"1","key":"3770_CR30","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.ccr.2012.05.016","volume":"22","author":"Y Mitsuishi","year":"2012","unstructured":"Mitsuishi Y, Taguchi K, Kawatani Y, Shibata T, Nukiwa T, Aburatani H, et al. Nrf2 redirects glucose and glutamine into anabolic pathways in metabolic reprogramming. Cancer Cell. 2012;22(1):66\u201379.","journal-title":"Cancer Cell"},{"issue":"8","key":"3770_CR31","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1158\/0008-5472.CAN-19-1363","volume":"80","author":"S Mukhopadhyay","year":"2020","unstructured":"Mukhopadhyay S, Goswami D, Adiseshaiah PP, Burgan W, Yi M, Guerin TM, et al. Undermining glutaminolysis bolsters chemotherapy while NRF2 promotes chemoresistance in KRAS-driven pancreatic cancers. Cancer Res. 2020;80(8):1630\u201343.","journal-title":"Cancer Res"},{"key":"3770_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2018.11.005","volume":"25","author":"Z Zhang","year":"2019","unstructured":"Zhang Z, Zhang L, Zhou L, Lei Y, Zhang Y, Huang C. Redox signaling and unfolded protein response coordinate cell fate decisions under ER stress. Redox Biol. 2019;25: 101047.","journal-title":"Redox Biol"},{"key":"3770_CR33","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/978-1-4939-8997-3_15","volume":"1914","author":"A Sophocleous","year":"2019","unstructured":"Sophocleous A, Huesa C. Osteoarthritis Mouse Model of Destabilization of the Medial Meniscus. Methods Mol Biol. 2019;1914:281\u201393.","journal-title":"Methods Mol Biol"},{"issue":"1","key":"3770_CR34","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/s41392-020-00402-5","volume":"5","author":"Z Liu","year":"2020","unstructured":"Liu Z, Xu W, Xia S, Gu C, Wang X, Wang Q, et al. RBD-Fc-based COVID-19 vaccine candidate induces highly potent SARS-CoV-2 neutralizing antibody response. Signal Transduct Target Ther. 2020;5(1):282.","journal-title":"Signal Transduct Target Ther"},{"issue":"7898","key":"3770_CR35","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41586-021-04385-3","volume":"602","author":"Y Cao","year":"2022","unstructured":"Cao Y, Wang J, Jian F, Xiao T, Song W, Yisimayi A, et al. Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies. Nature. 2022;602(7898):657\u201363.","journal-title":"Nature"},{"issue":"8","key":"3770_CR36","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1007\/s00198-009-1076-x","volume":"21","author":"TT Dam","year":"2010","unstructured":"Dam TT, Harrison S, Fink HA, Ramsdell J, Barrett-Connor E. Bone mineral density and fractures in older men with chronic obstructive pulmonary disease or asthma. Osteoporos Int. 2010;21(8):1341\u20139.","journal-title":"Osteoporos Int"},{"issue":"2","key":"3770_CR37","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.jcf.2009.11.007","volume":"9","author":"EF Shead","year":"2010","unstructured":"Shead EF, Haworth CS, Barker H, Bilton D, Compston JE. Osteoclast function, bone turnover and inflammatory cytokines during infective exacerbations of cystic fibrosis. J Cyst Fibros. 2010;9(2):93\u20138.","journal-title":"J Cyst Fibros"},{"issue":"6575","key":"3770_CR38","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1126\/science.abl4784","volume":"374","author":"DR Owen","year":"2021","unstructured":"Owen DR, Allerton CMN, Anderson AS, Aschenbrenner L, Avery M, Berritt S, et al. An oral SARS-CoV-2 M(pro) inhibitor clinical candidate for the treatment of COVID-19. Science. 2021;374(6575):1586\u201393.","journal-title":"Science"},{"issue":"9","key":"3770_CR39","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1016\/j.freeradbiomed.2009.06.030","volume":"47","author":"E Kansanen","year":"2009","unstructured":"Kansanen E, Kivel\u00e4 AM, Levonen AL. Regulation of Nrf2-dependent gene expression by 15-deoxy-Delta 12,14-prostaglandin J2. Free Radic Biol Med. 2009;47(9):1310\u20137.","journal-title":"Free Radic Biol Med"},{"issue":"3","key":"3770_CR40","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/s43018-021-00184-x","volume":"2","author":"S Mukhopadhyay","year":"2021","unstructured":"Mukhopadhyay S, Vander Heiden MG, McCormick F. The metabolic landscape of RAS-driven cancers from biology to therapy. Nat Cancer. 2021;2(3):271\u201383.","journal-title":"Nat Cancer"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-022-03770-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-022-03770-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-022-03770-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,27]],"date-time":"2022-11-27T01:27:38Z","timestamp":1669512458000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-022-03770-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,26]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["3770"],"URL":"https:\/\/doi.org\/10.1186\/s12967-022-03770-4","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,26]]},"assertion":[{"value":"8 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The animal study was reviewed and approved by the ethics committee of Shanghai Ninth People\u2019s Hospital (SH9H-2022-A95-1). Consent to participate is not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"549"}}